MEDICA 2026 | 16–19 November 2026 | Hall 6, Stall F37 | Düsseldorf, Germany
Precision-engineered single-use IV cannulas, safety catheters, and veterinary access systems validated for high-volume hospital supply and global distributor export.
Universal color-coded peripheral IV catheters with siliconized tri-bevel needles, radio-opaque FEP tubing, and ergonomic wings for stable indwelling placement.
Contact Us
Medical-grade Japanese stainless steel needle cannulas packaged in individual sterile blister packs. Optimized for outpatient surgery, EDs, and hospital GPOs.
Contact Us
Flexible winged butterfly needle sets specialized for small animal venipuncture, pet infusion therapy, and veterinary clinical monitoring applications.
Contact Us
High-flow 18G catheter featuring a needle-free side injection port for intermittent medication administration without interrupting primary intravenous lines.
Contact Us
Micro-gauge 22G-26G indwelling veterinary catheters designed to prevent vessel collapse in feline, canine, and exotic animal intravenous therapy.
Contact Us
Transparent blood flashback chamber engineered with a hydrophobic filter membrane for instant visual verification of successful vein penetration.
Contact Us
Safety-engineered veterinary catheter with automatic sharp encapsulation to shield clinicians and animal care handlers from accidental needlestick exposure.
Contact Us
Full spectrum veterinary IV safety portfolio supplied in bulk OEM configurations. Features kink-resistant polyurethane shafts and universal Luer lock fittings.
Contact UsAn authoritative technical guide for hospital procurement heads, GPO directors, and medical device importers on evaluating syringe geometry, cannula flow kinetics, and compliance frameworks.
Precision electrochemical polishing of 30G to 34G ultra-fine steel needles minimizes tissue trauma and displacement resistance during subcutaneous micro-injections.
Integrated needle-barrel designs eliminate dead volume inside the hub, ensuring exact dosage compliance for U-100 and U-40 insulin formulations without residual drug loss.
Integrated internal septa halt blood flow instantly upon needle withdrawal, reducing environmental contamination and occupational pathogen exposure in acute care environments.
In modern diabetes care and intensive care drug delivery, volumetric dosing accuracy is directly dependent on the physical geometry of the syringe barrel, plunger gasket, and needle assembly. As a primary manufacturer of insulin syringes and hypodermic injection systems, our engineering focus centers on mitigating "dead space"—the residual fluid volume remaining inside the syringe hub after complete plunger depression.
Traditional two-piece syringe configurations with detachable needles often retain between 0.04 mL and 0.08 mL of medication per dose. When administering high-potency U-100 insulin (where 0.01 mL equals 1 International Unit), such residual dead space results in significant cumulative drug waste and unpredictable dosage delivery. Our fixed-needle micro-barrel insulin syringes feature an integrated cannula directly staked into the syringe cylinder. This low dead-space design reduces residual volume to less than 0.003 mL, delivering three key clinical outcomes:
| Gauge Size | Outer Diameter (mm) | Inner Diameter (mm) | Recommended Clinical Application | Flow Rate Performance |
|---|---|---|---|---|
| 14G – 16G | 1.65 – 2.10 mm | 1.32 – 1.70 mm | Rapid trauma resuscitation, high-viscosity blood transfusion | > 270 – 450 mL/min |
| 18G – 20G | 0.90 – 1.25 mm | 0.65 – 0.90 mm | Surgical fluid delivery, routine adult inpatient IV access | 80 – 110 mL/min |
| 22G – 24G | 0.55 – 0.70 mm | 0.38 – 0.50 mm | Pediatric therapy, fragile veins, animal hospital care | 22 – 36 mL/min |
| 29G – 31G | 0.25 – 0.33 mm | 0.13 – 0.20 mm | Micro-subcutaneous insulin self-administration, growth hormone | Controlled micro-bolus |
The clinical safety of indwelling vascular catheters and hypodermic syringes depends entirely on polymer purity and raw material integrity. Cheap plasticizers can leach phthalates (such as DEHP) into lipid-based drugs or intravenous emulsions, introducing severe patient toxicity risks. At our integrated Sonepat manufacturing plant, every medical disposable is molded using 100% virgin medical-grade polypropylene (PP) and radiopaque Fluorinated Ethylene Propylene (FEP) or Polyurethane (PUR) compounds.
While FEP catheter shafts provide exceptional column strength for easy skin penetration, advanced PUR formulations offer superior softening characteristics upon entering the vascular lumen. Exposed to body temperature (37°C), PUR catheters soften by up to 70%, conforming to tortuous venous geometry, drastically reducing mechanical phlebitis and endothelial wall irritation over extended 72-hour indwelling periods.
Needle penetration force is the single greatest driver of patient discomfort during subcutaneous or intravenous insertion. We employ medical-grade Dow Corning silicone oil applied via automated ultra-fine spraying nozzles. This creates a uniform monomolecular coating across the tri-faceted bevel, reducing skin penetration drag forces below 0.35 Newtons.
Navigating international regulatory compliance requires flawless technical documentation and validated sterilisation parameters. Every single batch of insulin syringes, IV cannulas, and three-way stopcocks produced by Lars Medicare carries complete traceability from raw resin to finished shipping container.
Global healthcare systems are moving rapidly toward mandatory adoption of passive safety IV cannulas and self-disabling (AD) syringes to eliminate accidental needlestick injuries (NSIs). B2B buyers must prioritize suppliers with integrated auto-shielding patents.
Regulatory tightening in the EU and North America is outlawing halogenated polymers and phthalate plasticizers. Future-proof procurement requires non-PVC, DEHP-free infusion lines and recyclable polypropylene barrels.
Distributors are increasingly replacing middleman brand sourcing with factory-direct OEM partnerships. Custom artwork, multilingual IFUs, UDI barcodes, and localized gauge mixes offer higher gross margins and brand equity.
Operating fully integrated manufacturing facilities with an in-house toolroom, cleanroom molding, and dual international corporate headquarters in New Delhi, India, and Milton, Canada.
Unlike secondary assemblers who buy components from multiple vendors, Lars Medicare executes every single production stage under one unified quality management system:
With established distribution channels across 100+ countries, our export desk handles complex international trade terms and customs clearance support:
Technical and commercial clarity regarding product specifications, OEM customization, sample dispatch, and regulatory documentation.